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ABSTRACT
The purpose of the current experiment was to contribute to the existing literature
on the relationship between frequency of latency and amplitude of latency and simulator
sickness experienced in a head mounted display (HMD). Motion sickness has been
studied for decades in a variety of vehicles including ships, planes, trains and
automobiles. More recently virtual environments, including those utilizing an HMD have
been shown to generate significant sickness, often termed simulator sickness. Many
studies have linked system latency to simulator sickness and recent research has found
that with current technology latency is not a constant; but rather it varies systematically
over time due to sensor errors and clock asynchronization. One hundred twenty
participants were recruited and randomly assigned to one of four conditions (0.2 Hz
frequency of latency with 100 ms fixed amplitude of sinusoidal latency; 0.2 Hz frequency
of latency with 20 – 100 ms varying amplitude of sinusoidal latency; 1.0 Hz frequency of
latency with 100 ms fixed amplitude of sinusoidal latency; 1.0 Hz frequency of latency
with 20 – 100 ms varying amplitude of sinusoidal latency). Collected data were analyzed
using analysis of variance. A main effect of frequency of latency was found, and data
trended toward a main effect of amplitude of latency. Participants reported greater
sickness in 0.2 Hz frequency conditions and in the 1 Hz varying amplitude condition,
indicating both frequency and amplitude of latency contribute to simulator sickness and
are important factors to consider in regard to system latency. In conclusion, both
frequency and amplitude of latency play an important role in simulator sickness.
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INTRODUCTION
Purpose
The purposes of this study were: 1) to examine the sickening effects of
oscillations with fixed and varying amplitude of display latency within an HMD at the
0.2 Hz and 1.0 Hz frequencies and 2) to further examine the interaction effects of
frequency and amplitude of latency on the occurrence of simulator sickness.
Motion Sickness and Simulator Sickness
Motion sickness has been a well-known and well-documented problem for
hundreds of years, dating back to Greek scholars twenty-five centuries ago, and
mentioned by Hippocrates, Julius Caesar, Lawrence of Arabia, Charles Dickens, and
Admiral Nelson (Lawther & Griffin, 1986; Money, 1972). Despite years of study,
motion sickness continues to be a problem today. The most common symptoms
associated with motion sickness are vomiting, sweating, salivation, apathy, fatigue,
stomach awareness, disorientation, dizziness, and incapacitation (Kennedy, Drexler, &
Kennedy, 2010). The most widely accepted theory explaining motion sickness is the
sensory conflict theory (Reason & Brand, 1975; Oman, 1990).
Similarities between oscillations in real and simulated motion. Bijveld et al.
(2008) directly compared real and simulated motion and how they relate to sickness using
an off vertical axis rotation paradigm. They found that simulated motion is less
nauseogenic than actual motion in both sickness rating and time to sickness. They also
identified the three most common symptoms for real motion to be bodily warmth,
stomach awareness, and nausea and the three most common for simulated motion were
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headache, dizziness, and nausea. They found a significant difference in headache rating
and noted that nausea was common among both real and simulated motion.
Sensory conflict theory. Reason and Brand (1975) introduce sensory conflict
theory as a contradiction between information processed through the visual system and
input received from the vestibular system (Emmerik, Vries, & Bos, 2011). The nervous
system receives conflicting information and motion sickness results. Sensory conflict
theory is used to explain when there is interference in inductive inferences made by
animals as they interact with the world. These interferences are thought to lead to motion
sickness.
Reason (1978) explains two components of sensory conflict theory. First, all
situations producing motion sickness can be described as a condition in which motion
perceived by the eyes, vestibular system, and non-vestibular proprioceptors differ from
each other. Second, in order for motion sickness to occur, the vestibular system must be
involved, either directly or indirectly. Both of these components are involved in
perceiving conflicting information from different sensory systems, resulting in motion
sickness.
The vestibular system. The vestibular system and the visual-vestibular
interaction both play a key role in experiencing motion sickness and simulator sickness.
Each ear contains a vestibular apparatus located in the bony labyrinth of the inner ear.
The vestibular apparatus is used to sense head movements and react to them via response
signals. These response signals aid in eye movements, posture and balance, and
perception of motion and orientation (Stoffregen, et al., 2002). The vestibular apparatus
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is crucial for everyday functioning, including, but not limited to standing, walking and
reading.
The body has a vestibulo-ocular reflex that aids in vision during head movements
by stabilizing images on the retina during head motion. When the head moves, the
vestibular apparatus senses the acceleration and deceleration and signals the oculomotor
system, providing information about direction and rate of movement. Then the
oculomotor system compensates for the movement with eye movements in the opposite
direction of the head movement. Discrepancies between information from the vestibular
apparatus and the visual system (i.e. visual-vestibular interactions) can cause conflict
between what the body feels and what the body sees, which can result in discomfort and
motion sickness.
Virtual Environments and Head Mounted Displays
Virtual Environments. Virtual environments simulate human perceptual
experience by creating an impression of something that is not there in reality (Carr,
1995). They are often used to advance fields such as medicine, engineering, education,
design, training, and entertainment (Stanney, Mourant, & Kennedy, 1998). Virtual
environments can be used for training through simulation when on-the-job training is too
risky. Training with virtual environments instead of on-the-job can possibly prevent loss
of money, equipment, or health of workers. When dealing with highly trained
professionals (e.g. warfighters or aviators), there are many benefits for using virtual
environment HMD technologies for training or rehearsal (Gorman, 1990; Sowndarajan,
Wang, & Bowman, 2008). These technologies have the ability to create various
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dangerous and stressful scenarios for the trainee without having them endure the real life
consequences of the situation such as poor performance, injury, or death.
Head Mounted Displays. Head mounted displays (HMDs) are head-worn
personal display units used to view a real world scene or a virtual environment. They are
made up of a helmet with an individual display or pair of displays consisting of small
CRTs or liquid-crystal displays (LCDs). HMDs can be monocular (projecting an image
into a single display), binocular (projecting disparate images through individual displays
for each eye), or bi-ocular (projecting identical images to both eyes through two
displays). Typically, HMDs have head tracking capabilities to track the user’s visual
point of reference within the virtual environment. Head tracking works to constantly
update the visual display as the user moves with the HMD. The head tracker monitors
the user’s head movements and sends the user’s position in space back to the computer.
The computer then processes the information and updates the visual display viewed by
the user so the display matches the position of the user’s head.
HMDs and simulator sickness. Exactly why HMD generated virtual
environments make people sick is unknown. Hypothesized factors include the
discrepancy of the display from the real world, system lag, narrow field of view, low
display resolution, and fidelity within HMDs. Field of view in HMDs is much smaller
than the 360° field of view in the real world, and even smaller than the 180° - 200° field
of view in humans (Toet, Jansen & Delleman, 2007). A smaller field of view necessitates
larger head movements while wearing the HMD. Resolution is also diminished from the
real world, resulting in low quality image displays. Generally, there is a tradeoff between
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weight, resolution and/or field of view. The fidelity of the simulation also plays a role in
the discrepancy between the real world environment and the display within the HMD.
While high fidelity images can lessen this discrepancy, there is also evidence that higher
fidelity HMDs increase symptoms of simulator sickness (Kennedy, Hettinger, &
Lilenthal, 1990).
System lag (also called display update delay or end-to-end latency) is innate in
HMDs and another possible cause of sickness. Lag can be defined as the duration
between a head movement and the time it takes the display to update. System lag in an
HMD can cause visuo-vestibular conflicts. These conflicts are similar to those predicted
in Reason & Brand’s sensory conflict theory of motion sickness (Reason & Brand, 1975).
Several studies have looked at simulator sickness in HMD generated virtual
environments. In a study by Howarth and Costello, participants reported a significantly
greater amount of simulator sickness symptoms after using an HMD than after using a
visual display unit (Howarth & Costello, 1997). These results were explained by sensory
conflict theory due to visuo-vestibular conflicts that occur while using an HMD. A more
recent study looked at simulator sickness while using an HMD to capture real world
video scenes (as opposed to a virtual environment; Moss, Scisco, & Muth, 2008). It was
found that peak sickness scores were significantly higher while wearing the HMD to
view a real world scene compared to not wearing the HMD.
System latency. System latency is innate in the system and described by the time
it takes to update the system from initial movement to actuation (e.g., the time it takes to
sense a head movement, process the movement, and actuate an update event of the visual
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scene in the display). Latency can also be defined in terms of display delay, which is the
sum of all temporal delays between the system input and the output of the visual scene
displayed in the HMD (Moss, et al., 2011). These delays could be due to many things
including (but not limited to) processing times, transport times, update rates, and clock
asynchronicity.
System latency is generally in the tens to hundreds of milliseconds (Wu, Dong, &
Hoover, 2013). Despite the small range, the latency is prominent enough to be sensed by
humans in certain situations (Moss, et al., 2010).
Because system latency occurs on the millisecond scale, it is challenging to
measure. While it can be measured both internally and externally, measuring it internally
does not include the time data may spend in buffers, time spent by the sensor to acquire
data, or time spent by the actuator to output data. Therefore, it is preferred to measure
latency externally using a so-called outside observer method. There are two ways to
measure latency externally. First, a camera can be used to continuously monitor the
system; second, event-driven instrumentation can be used to measure discrete events
(Wu, Dong, & Hoover, 2013). As it has been found that latency is not constant, but
rather varies continuously, the preferred method is the continuous camera monitor.
Latency is a characteristic of human sensory processing that follows from the
vestibular-ocular reflex (VOR) that occurs during head movements. VOR is used to
stabilize the visual environment on the retina and consists of compensatory eye
movements that occur in the opposite direction of the head movement. It has been
calculated that the average latency of the VOR is 8.6 ms (Collewijn & Smeets, 2000).
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Many studies have looked at the human perceptual threshold for system latency, and
results have varied. A 2010 study examined human perceptual threshold for lag using a
rotating chair and optokinetic drum paradigm (Moss, et al., 2010). Results from this study
showed a lag threshold of 147.64 ms ± 84.91 ms. Other experiments using HMDs to
determine lag thresholds have varied greatly from 14.3 ms – 245 ms (Allison, et al.,
2001; Ellis, et al., 2004; Ellis, et al., 1999; Ellis, et al., 1999). Due to the varying results
of previous studies, the human lag threshold may fluctuate based on HMD application as
well as user characteristics such as experience level with HMDs (Moss, et al., 2010).
Some researchers theorize technological limitations such as update delay, fidelity,
field of view, and resolution, in HMDs lead to simulator sickness (Kennedy, Hettinger, &
Lilienthal, 1990; Pausch, Crea, & Conway, 1992), and even though many technological
advances are being made, simulator sickness is still prevalent (Kennedy, et al., 2003).
Further research needs to be completed to have a better idea of what the causal factors of
simulator sickness actually are.
Latency and Simulator Sickness. System latency is a common problem in
HMDs because it is linked to simulator sickness. Lag (a specific type of system latency)
is the time between head movements and the resulting movement in the visual display
and is linked to simulator sickness in an HMD (DiZio & Lackner, 1997). Display delays
cause a temporal mismatch between head movement and scene movement and have been
found to increase the likelihood of simulator sickness (Draper, et al. 2001).
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Figure 1.1: Typical configuration with components operating on independent clocks
causing non-constant latency in the system (From Wu et al., 2013).
System latency confounds pointing and object location tasks (Teather, et al.,
2009), catching tasks (Lippi, et. al, 2010), and ball bouncing tasks (Morice, Siegler, &
Bardy, 2008). It has also been found that higher fidelity images produce increased
system latency (Hettinger & Riccio, 1992). In the past, latency was thought of as a
constant, but recent research has shown that latency can vary over time (Wu, Dong, &
Hoover, 2013; Moss & Muth, 2011). It is probable that the variability of latency,
specifically amplitude of latency, leads to increased simulator sickness (St. Pierre, 2012).
Frequency and Amplitude of Motion. Originally, motion sickness research
focused on transportation motion and involved movement from land vehicles, ships, and
aircraft. Most researchers focused on the vertical heave motion often experienced while
on a boat or ship and many studies concluded peak levels of nausea occurred while
experiencing motion with frequencies less than 1.0 Hz (Alexander, et al., 1947; O’Hanlon
& McCauley, 1974; Lawther & Griffin, 1988; Duh, et al., 2004). Figure 2 shows a plot
of the motion sickness model by frequency and acceleration based on O’Hanlon and
McCauley’s findings with their motion generator. In O’Hanlon and McCauley’s study on
motion sickness, 308 participants sat in a motion generator with 14 conditions for up to
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two hours. It was found that frequencies around 0.2 Hz had the highest motion sickness
incidence, with 0.167 Hz being the most nauseogenic. Conversely, results also showed
that humans are able to tolerate higher accelerations at higher frequencies (0.5 – 1 Hz).
From this study, a preliminary model of motion sickness was able to simultaneously link
incidence of motion sickness to the frequency and acceleration parameters of vertical
periodic motions and a curvilinear relationship was shown between wave frequency and
motion sickness incidence. O’Hanlon and McCauley provided evidence that frequency is
a critical factor in vertical heave motion and the incidence of motion sickness.

Figure 1.2: Relationship of MS to wave frequency and average acceleration
(From O’Hanlon & McCauley, 1974)
After early research of the effect of vertical heave motion on sickness symptoms,
many experiments were conducted to examine the effects of frequency on horizontal
motion. Golding, Phil, and Markey (1996) conducted a study to examine how frequency
affects motion sickness on linear oscillations in the horizontal direction. They looked at
0.205, 0.35, and 0.5 Hz frequencies of motion and their effect on motion sickness. The
upper frequency of 0.5 Hz was chosen under the assumption that sickness would decline
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at higher frequencies for horizontal motion, as it did with vertical motion. Results from
this study confirmed that frequency of motion affects motion sickness with horizontal
oscillations in a similar way as with vertical oscillations. It was found that
nauseogenicity of motion increased and time to sickness significantly decreased at lower
frequencies, with time to sickness in the 0.205 Hz condition being significantly less than
in the other two conditions.
Later studies by Golding and colleagues had similar findings when looking at
different frequency conditions. When looking at frequencies between 0.35 – 1.0 Hz, a
significant effect was found with sickness increasing as frequency decreased (Golding et
al., 1997). Specifically, they found time to sickness was significantly less in the 0.35 Hz
condition than in the higher conditions. They concluded that with horizontal oscillatory
motion, the nauseogenic potential is significantly reduced at frequencies above 0.5 Hz
and continues to lessen all the way up to 1.0 Hz. From these results Golding et al. also
concluded that the frequency component is central to the nauseogenicity of linear motion.
After the two previous studies, Golding, et al. examined the frequencies above
and below the most nauseogenic frequency of 0.2 Hz (Golding et al., 2001). In this
experiment, 0.1, 0.2, and 0.4 Hz frequencies were examined and it was found that
nauseogenicity of motion is greatest at frequencies around 0.2 Hz and significantly
decreases above and below. They found time to sickness was significantly less in the 0.2
Hz condition than the 0.1 and 0.4 Hz conditions. They also found that more subjects
reached the maximum level of nausea before the maximum time of the study in the 0.2
Hz condition than the other two conditions. Another study examining horizontal motion
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by Donohew & Griffin (2004) was conducted to examine the effect of lateral oscillation
on motion sickness at frequencies between 0.0315 – 0.2 Hz. In this experiment, subjects
exposed to the higher frequencies (0.16 – 0.2 Hz) experienced more symptoms and gave
significantly higher ratings for sickness symptoms than those exposed to frequencies
below 0.16 Hz. No significant difference was found between 0.16 – 0.2 Hz frequencies.
These results contribute to previous conclusions that frequency of motion is fundamental
to incidence of motion sickness, as well as the conclusion that humans are highly
susceptible to motion sickness around 0.2 Hz.
A study to determine the nauseogenicic effects of tilt, exposure duration and
frequency for the optokinetic equivalent of off vertical axis rotation also found 0.2 Hz
frequency to yield the highest sickness symptoms (Goulding, et al., 2009). The authors
speculated that the 0.2 Hz frequency may be a causal mechanism that evokes sickness in
widely differing stimuli. In other words, while many different types of stimuli may
contribute to symptoms of motion sickness, perhaps one common trait among these
stimuli is the 0.2 Hz frequency of motion.
Frequency and amplitude of latency. There are two main components of latency
fluctuation: frequency of latency and amplitude of latency. Wu, Dong, & Hoover
(2013), recently found that latency is variable and changes due to a drift in sensor error.
They found the drift to be within the range of 0.5 to 1.0 Hz with measured oscillations in
amplitude of around 20-100 ms. Frequency of latency refers to the rate at which the
latency changes, measured in cycles per second (Hz). Amplitude of latency refers to the
range of time the image is lagging behind. Figure 3 depicts latency at both constant
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frequency and constant amplitude and figure 4 shows constant frequency of latency with
varying amplitude of latency.

Figure 1.3: Latency with 0.2 Hz frequency and 100 ms amplitude.

Figure 1.4: Latency with 0.2 Hz constant frequency and amplitude varying from
20 – 100 ms.
Just as frequency and amplitude of motion are thought to be fundamental to
motion sickness, frequency and amplitude of latency are thought to be fundamental in
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simulator sickness. It has been hypothesized that sickness in these two domains may
have a similar relationship with frequency, namely that sickness is maximized around 0.2
Hz frequency. However, there has been some discrepancy in the previous research on the
frequency of maximum nauseogenicity for simulator sickness and only a limited amount
of frequencies have been tested. Duh et al. (2004) identified a “cross-over frequency” of
0.06 Hz, which they defined as the visual and vestibular self-motion systems is
maximum. The cross-over frequency occurs due to conflicting visual and vestibular selfmotion cues and they claimed it has the highest potential for simulator sickness. Unlike
that of real motion, Duh and colleagues claim that the most nauseogenic frequency for
simulated motion is 0.06 Hz instead of 0.2 Hz. However, this theory was never tested
with a purely visual stimulus.
Recently, Diels and Howarth (2013) conducted a study to examine the effect of
frequency on simulator sickness using a purely visual stimulus. They included
frequencies between 0.025 and 1.6 Hz, and contrary to Duh et al.’s claims, they identified
humans to be highly susceptible to sickness when the frequency is between 0.2 – 0.4 Hz.
Results from Diels and Howarth’s study showed increasing sickness with increasing
frequency for the range of 0.025 – 0.2 Hz and decreasing sickness with increasing
frequency for the range of 0.2 – 1.6 Hz. They also found that 0.2 Hz yielded higher
sickness ratings and shorter times to sickness than the other frequencies.
These results indicate that humans are sensitive to 0.2 Hz frequency for both real
and simulated motion and demonstrate the similarity in sickness patterns for both real and

13

simulated motion, where nauseogenicity occurs around 0.2 Hz and steadily decreases at
frequencies above 0.2 all the way to 1.6 Hz.
Both frequency and amplitude of motion were examined in St. Pierre’s 2012
study. This study looked at the effect of added latency, frequency of latency, and fixed
and varying amplitude of sinusoidal latency on simulator sickness. The results from this
experiment showed that 0.2 Hz was most sickening with latency varying from 20 – 100
ms. These results agree with Diels and Howarth’s finding that humans are highly
susceptible to sickness around 0.2 Hz for both real and simulated motion. It also
emphasizes the involvement of varying amplitude of latency and its effect on simulator
sickness.
Latencies that vary over time are being examined and compared to latencies that
remain constant over time. All latencies in this paper are written as latency(t) = A sin(2
pi f t) + K + B, where B is the existing system baseline. This formula can be used to
describe both constant and sinusoidally varying latencies. If f = 0 or A = 0 then the
latency is constant; otherwise the latency varies sinusoidally over time. Latency is
referred to by providing values for (A, f, K, B). For example, a latency of (A = 0, f = 0,
K = 130 ms, B = 70 ms) refers to a constant latency of 200 ms. A latency of (A = 50 ms,
f = 0.2 Hz, K = 100 ms, B = 70 ms) refers to a sinusoidal latency with a baseline of 170
ms, amplitude of 50 ms and frequency of 0.2 Hz. Note that the baseline must always be
larger than the amplitude because we do not consider cases where the latency can be
negative. We also study latencies where the frequency and amplitude are varied period to
period. We denote these by providing a range for A and/or f. For example, a latency of
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(A=20-100 ms, f=0.2 Hz, K=120) denotes a latency that changes amplitude to a random
value between 20-100 ms at the start of each period. To ensure clarity, all latencies will
henceforth be described by providing values or ranges for (A, f, K).
Frequency and Amplitude of Motion and Their Relationship to Motion Sickness
A recent study looked at different conditions of frequency of latency and
amplitude of latency within an HMD to see which would be most sickening (St. Pierre,
2012). Four conditions were tested: (A = 0, f = 0, K = 0 ms, B = 70 ms), (A = 0, f = 0, K
= 200 ms, B = 70 ms), (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms), and (A = 20 –
100 ms, f 0.2 Hz, K = 100 ms, B = 70 ms). Participants were required to complete an
object location task that required them to make head movements to find different objects
around the room while wearing an HMD. A significant increase in simulator sickness
symptoms was found in varying amplitude conditions compared to fixed amplitude
conditions. This finding implies that the varying amplitude is the cause for increased
simulator sickness symptoms. However, varying amplitude was only examined with the
known nauseogenic 0.2 Hz frequency, confounding the amplitude and frequency effects.
If it truly was the varying amplitude that caused sickness, then varying amplitude of
latency on its own (without being combined with 0.2 Hz frequency) should result in
increased sickness symptoms. This idea needs to be further investigated so the role of
frequency of latency and amplitude of latency in simulator sickness can be fully
understood.
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Present Study
The purpose of the present study was to further examine the interaction between
frequency and amplitude of latency within an HMD. Specifically, the relationship
between frequency of latency and increased simulator sickness was assessed. The
Applied Human Psychophysiology Laboratory at Clemson University has been looking at
the effects of HMDs on simulator sickness. In 2008, effects of update delay, image scale
factor, and peripheral vision on simulator sickness were examined (Moss, 2008).
Marginal support was found for 200 ms update delay increasing simulator sickness in
participants. Wu, Dong, and Hoover (2013), also from Clemson University, then found a
new way to continuously measure end to end latency and discovered that update delay, or
latency, in HMDs in not constant, but variable. They hypothesized that this variable
latency contributes to the simulator sickness when using an HMD. In 2012, St. Pierre
looked at both constant offset and variable latency in HMDs and their relationship to
simulator sickness. He found variable latency resulted in significantly higher sickness
scores than constant offset. He also found partial support for both 0.2 Hz frequency and
varying amplitude of sinusoidal latency causing increased sickness scores. The current
study further explored frequency and amplitude of latency in an HMD. A known
sickening frequency (f = 0.2 Hz), and a known non-sickening frequency (f = 1.0 Hz)
were coupled with fixed amplitude of sinusoidal latency (A = 100 ms) and varying
amplitude of sinusoidal latency (A = 20 – 100 ms) to further explore their relationship to
simulator sickness.
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As previously discussed, St. Pierre (2012) recently found a relationship between
amplitude of latency and simulator sickness. However, the relationship between
frequency of latency and simulator sickness has not been fully investigated. Therefore,
the frequency component of latency in HMDs needs to be assessed further to completely
explore the relationship between frequency of latency and simulator sickness in HMDs.
To do this, a known nauseogenic frequency of latency (f = 0.2 Hz) and a known less
nauseogenic frequency of latency (f = 1.0 Hz) were used along with fixed amplitude of
sinusoidal latency (A = 100 ms) and varying amplitude of latency (A = 20 – 100 ms)
conditions. By using the known nauseogenic frequency of 0.2 Hz and a less nauseogenic
frequency of 1.0 Hz, one can determine whether the varying amplitude of latency is
actually the causal mechanism for increased sickness or if it is the varying amplitude of
latency paired with the known nauseogenic 0.2 Hz frequency that causes increased
sickness.
The frequency determined to be sensitive for humans, 0.2 Hz, was chosen as the
nauseogenic stimulus due to the amount of previous research that provides evidence for
the claim that humans are highly susceptible to sickness when the frequency is around 0.2
Hz (O’Hanlon & McCauley, 1974; Donohew & Griffin, 2009; Donohew & Griffin, 2004;
Golding, Phil, & Markey, 1996; Golding, et al., 2001; Godling, et al., 2007; Bijveld, et
al., 2008;Godling, et al., 2009; St. Pierre, 2012; Diels & Howarth, 2013). The less
nauseogenic frequency of 1.0 Hz was chosen due to the known significant sickness drop
off after 0.5 Hz that has been shown to continue decreasing to 1.0 Hz (O’Hanlon &
McCauley, 1974; Golding, et al., 1997; Diels & Howarth, 2013).
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Hypotheses. The first hypothesis was a main effect of frequency, i.e., that there will
be an increased level of simulator sickness and motion sickness experienced in the 0.2 Hz
frequency of latency condition than in the 1.0 Hz frequency of latency condition. This
hypothesis is supported by the numerous experiments previously conducted that
determined humans are highly susceptible to sickness around 0.2 Hz frequency
(O’Hanlon & McCauley, 1974; Donohew & Griffin, 2009; Donohew & Griffin, 2004;
Golding, Phil, & Markey, 1996; Golding, et al., 2001; Godling, et al., 2007; Bijveld, et
al., 2008;Godling, et al., 2009; St. Pierre, 2012; Diels & Howarth, 2013).
The second hypothesis was a main effect of amplitude, i.e., that there will be an
increased level of simulator sickness and motion sickness experienced in the varying
amplitude of sinusoidal latency condition than in the fixed amplitude of sinusoidal
latency condition. This result has been shown in St. Pierre’s study with both conditions
having f = 0.2 Hz (St. Pierre, 2012). However, it has not been looked at using a known
less nauseogenic frequency of 1.0 Hz.
The third hypothesis was that there would be a significant interaction between
frequency of latency and amplitude of latency. If the evidence supports this hypothesis, it
would replicate the results found by St. Pierre (2012).

METHODS
Participants
A power analysis was conducted using “PS: Power and Sample Size” and used
frequency of latency data collected from St. Pierre’s 2012 study. The current study used
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a continuous response variable from independent control and experimental subjects with
one control per experimental subject. In a previous study the response within each
subject group was normally distributed with standard deviation 38.67 (St. Pierre, 2012).
If the true difference in motion sickness between the experimental and control means is
30.05, as found by St. Pierre (2012), 27 experimental subjects (f = 0.2 Hz) and 27 control
subjects (f = 1.0 Hz) needed to be studied to be able to reject the null hypothesis with the
population means of the experimental and control groups are equal with probability
(power) 0.8. The Type 1 error probability associated with this test of the null hypothesis
was set to 0.05. The sample size was increased initially to 30 subjects per each
experimental condition (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms), (A = 20 – 100
ms, f = 0.2 Hz, K = 100 ms, B = 70 ms) and 30 subjects per each control condition (A =
100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms), (A = 20 – 100 ms, f = 1.0 Hz, K = 100 ms,
B = 70 ms) to account for the unknown magnitude of effect of amplitude of latency.
However, since the interaction between frequency and amplitude of latency is of interest,
the study was over-powered, with 60 subjects in the experimental conditions and 60 in
the control conditions to make sure there was enough power to see the interaction if there
is one.
One hundred twenty participants were recruited from Clemson University’s
student population. Participants were recruited via the Clemson Psychology Research
System subject pool recruitment system and word of mouth. Those responding from the
subject pool were compensated $10 for their time and were given course credit through
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the Clemson Psychology Research System; those responding from word of mouth were
compensated $10 for their time.
All recruited participants completed a screening questionnaire to determine if they
were eligible for participation. Individuals who self-reported high susceptibility and
frequency of MS symptoms were excluded from the experiment. Additionally,
individuals who had past experience with virtual environments or HMDs were excluded
from the experiment. Individuals who self-reported any history of brain, heart, stomach,
eye (other than corrected vision), or inner ear problems, or who were pregnant were not
eligible for this experiment. If the individual had corrected vision, they were required to
wear contact lenses to participate, as the HMD could not fit over glasses. Finally,
participants who reported feeling sick or less than their normal physical state were
rescheduled and sent home for the day. Participants were asked to abstain from alcohol,
nicotine, and caffeine for 12 hours prior to their appointment. They were also asked to
avoid intense physical activity the hour before their appointment.
Design
This experiment had a 2 x 2 between subjects design (see figure 5). A between
subjects design was chosen to avoid adaptation effects between conditions among
subjects and to reduce potential participant withdrawal between each condition.

Amplitude

100 ms fixed

Frequency
1 Hz
.2 Hz
N = 30
N = 30

20 – 100 ms varying

N = 30

N = 30

Table 2.1: 2 x 2 between subjects design
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The dependent variable was incidence of simulator sickness. The two
independent variables were frequency of latency and amplitude of latency, each with two
levels. The amplitude of latency levels (A = 100 ms and A = 20 – 100 ms) were used by
St. Pierre, and were found to have a significant effect on simulator sickness (2012). The
frequency of latency levels were f = 0.2 Hz and f = 1.0 Hz. The 0.2 Hz condition was
chosen because 0.2 Hz has been found to be the most sickening frequency for humans in
other areas. According to previous motion sickness research, humans are highly
susceptible to sickness around 0.2 Hz frequency (O’Hanlon & McCauley, 1974;
Donohew & Griffin, 2009; Donohew & Griffin, 2004; Golding, Phil, & Markey, 1996;
Golding, et al., 2001; Godling, et al., 2007; Bijveld, et al., 2008;Godling, et al., 2009; St.
Pierre, 2012; Diels & Howarth, 2013). Previous research also found a quick decrease in
nausea at 0.5 Hz, and this drop off is known to continue to 1.0 Hz (Golding, et al., 1997).
This is why 1.0 Hz. was chosen as the second condition. Participants were randomly
assigned to one of the four conditions.
Materials and Apparatus
HMD. A ProView TM XL 50 HMD (Kaiser Electro-Optics, Inc.) was used for
this experiment, shown in figure 6. The XL 50 is a bi-ocular HMD with a resolution of
1024 x 768 and a frame rate of 60 Hz. Eyecups made out of rubber-like molding made
specifically for the XL 50 were used to occlude external light from the environment.
This is necessary because the camera is mounted on top of the HMD and there was a
discrepancy in height between the environment and the HMD display.
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Figure 2.1: Picture of HMD that will be used in this experiment
The HMD had a 50° field of view (FOV) diagonally, 30° FOV vertically, and 40°
FOV horizontally. It weighed 35 oz prior to camera being mounted.
Digital Camera. A Uniq UC-610CL color digital CCD camera was used to
capture images from around the laboratory in this study. This camera was mounted atop
the HMD. The camera resolution was 659 X 494 active pixels at a frame rate of 110 Hz.
The camera had a lens mount platform C-mount and used a 1/3” progressive scan CCD
imager with R, G, and B primary color mosaic filters. The camera weighed 200 g.
A Dalsa X64 CL Express™ PCI camera link frame grabber for image capture was
installed on a Windows XP computer containing a 3.2 Ghz Pentium IV processor and 2
GB of RAM. A 256 Mb PCI Express™ video card was used. The captured images from
the camera were projected on the HMD display as well as the computer monitor for the
experimenter to observe.
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Update Delay Program. The manipulation of system latency was made possible
by an in-house program developed by Salil Banerjee, a graduate student in the Electrical
and Computer Engineering Department at Clemson University. The following
description of how the program provided additional latency to the system was provided
via personal communication from former graduate student, Tom Epton, in the Electrical
and Computer Engineering Department at Clemson University, which can be found in
Moss (2008; cited from St. Pierre, 2012).
The camera operates at 110 Hz and therefore captures an image every 9.09 ms.
Rather than immediately displaying the captured image, it is placed in an internal
buffer. The amount of delay that is added to the system depends on how many
images are placed into the buffer. For example, to add in 27 ms of delay, three
consecutive captured images from the camera are placed into the buffer. When the
4th image is placed in the buffer, the first image is removed and displaced,
leaving three images remaining in the buffer. In other words, as soon as the
number of images is placed into the buffer to satisfy the delay amount, the buffer
then acts like a queue with FIFO (First In First Out) ordering. When a captured
image is placed at the tail of the queue, the image at the head of the queue is
removed and displayed.
Ryan Mattfeld, a graduate student in the Electrical and Computer Engineering
department at Clemson University modified the update delay program to be able to create
the specific latencies used in this experiment: (A = 100 ms, f = 0.2 Hz, K = 100 ms, B =
70 ms), (A = 20 – 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms), (A = 100 ms, f = 1.0 Hz,
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K = 100 ms, B = 70 ms), (A = 20 – 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms), and
assisted with the validation of this program.
Validating the update delay program. To confirm the fidelity of the update delay
program the amplitude of latency and frequency of latency were measured to confirm the
program operated accurately. The outside observer method was used to ensure the
program was measuring the correct frequency and amplitude of latency. The procedure
involved using a camera as a sensor and the HMD display as an actuator. A black bar
was moved across a white background and a high-speed camera was used to capture both
the sensed and actuated images. The latency was measured between the sensed and the
actuated images of the black bar moving across the white background.
When measuring the latency using this method it is difficult to see multiple cycles
of latency, especially when f = 0.2 Hz. When frequency is 0.2 Hz, it takes 5 seconds to
complete one cycle. However, each recording using the outside observer method is a
maximum of 2 seconds, resulting in only around 1/5 of a latency cycle. This makes it
impossible to see the varying amplitude component of the latency. Because of this, 10
recordings of each condition using the outside observer method were made and a range of
frequency and amplitude values were looked at using sinusoidal fits to ensure the update
delay program was doing what was expected. This data can be seen in Appendix A.
Sinusoidal fits were applied to the raw data using the following equation:
y = A*sin[(1/f)x + Φ] + k
where ‘A’ represents amplitude of latency, ‘f’ represents frequency of latency, ‘Φ’
represents phase shift and ‘k’ represents constant offset. Values were found first using
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this equation with no fixed variables, and then by fixing k to 180, and A and f to the
appropriate values for the condition being tested. Figure 7 shows what the latency would
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Figure 2.2: simulated latency over a 20 second time period for each condition.
The x-axis depicts time in seconds and the y-axis depicts latency in milliseconds. Graph
A represents latency with (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph B
represents latency with (A = 20 – 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph C
represents latency with (A = 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms); graph D
represents latency with (A = 20 – 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms).
Results from the outside observer method show that the software was able to
produce the four conditions in the HMD display, shown in figure 8. Figure 8 shows a
graph of the frequency and amplitude of latency from each condition. Figure 8A shows
results from latency with

(A = 20 – 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms);

figure 8B shows results from latency with (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70
ms); figure 8C shows results from latency with (A = 20 – 100 ms, f = 1.0 Hz, K = 100
ms, B = 70 ms); figure 8D shows results from latency with (A = 100 ms, f = 1.0 Hz, K =
100 ms, B = 70 ms). Each of these figures represents the change in system latency over
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time. Appendix B shows more examples of latency graphs from the outside observer
method. Figure 9 shows graphs of the alignment of event properties between the sensed
and actuated images from before motion starts to after it stops. The areas of the graph
that overlap represent both images being in the same position. The discrepancy between
the lines represents the latency in the system.

A

B

C

D

Figure 2.3: Graphs displaying results from the outside observer method. The xaxis depicts time in milliseconds and the y-axis shows latency in milliseconds. Graph A
latency with (A = 20 – 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph B represents
latency with (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph C represents
latency with (A = 20 – 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms); graph D represents
latency with (A = 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms).
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A

B

C

D

Figure 2.4: Graphs showing alignment between sensed and actual image. Graph
A latency with (A = 20 – 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph B represents
latency with (A = 100 ms, f = 0.2 Hz, K = 100 ms, B = 70 ms); graph C represents
latency with (A = 20 – 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms); graph D represents
latency with (A = 100 ms, f = 1.0 Hz, K = 100 ms, B = 70 ms).
Motion Sickness History Questionnaire. The Motion Sickness History
Questionnaire (MSHQ) is a diagnostic tool used to assess susceptibility to motion
sickness based on participants’ self-report of relevant sickening experiences and was used
to measure previous experience with motion sickness (Reason & Brand, 1975). It also
assesses how frequently participants were involved in certain modes of traveling (plane,
boat, train, etc.) and how frequently those modes of travel initiated motion sickness
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symptoms. The MSHQ results in one total score, and the higher the score, the more
susceptible to motion sickness the individual is.
Simulator Sickness Questionnaire. The Simulator Sickness Questionnaire
(SSQ) is a measure of motion sickness symptoms in a virtual environment, called
simulator sickness (Kennedy et al., 1993). This questionnaire requires participants to
respond to how they are feeling regarding 16 different sickness symptoms on a scale of
none, slight, moderate, or severe, with corresponding raw scores of 0, 1, 2, 3. There are
three subscales of this questionnaire: oculomotor, disorientation, and nausea. Each
participant yielded a Total Severity (TS) score for each subscale by summing the
individual items under each subscale. The maximum score is 224.4. The creators of the
questionnaire stated SSQ scores between 5-10 indicate minimal symptoms, 10-15
indicate significant symptoms, and scores above 20 indicate a bad virtual environment
simulator.
Motion Sickness Assessment Questionnaire. The Motion Sickness Assessment
Questionnaire (MSAQ) is a multidimensional measure assessing motion sickness
(Gianaros et al., 2001). There are 16 items on this questionnaire, and participants
responded to how they are feeling based on each of the items. Participants responded
using a 9-point scale (1 = not at all, 9 = severe) for each item and the maximum score is
144.
Room Layout. An object location task was used to challenge the participants’
visual-vestibular interaction. Participants were required to locate 8 objects around the
laboratory throughout the experiment. They did this by making head movements while
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wearing the HMD. The layout of the room is shown in Figure 10. The objects, shown in
figure 11, were the office door (A), clock (B), flag (C), fire extinguisher (D), front door
(E), first aid kit (F), fan (G), and curtain (H). Participants’ performance on the object
location task was judged based on whether the object being located was in the visual
display before the next object needed to be located.

Figure 2.5: Footprint of room layout for the object location task

Figure 2.6: Picture of objects that were found in the object location task during trials.
Procedure
Upon arrival, each participant received a copy of the Clemson University Internal
Review Board approved informed consent form to read and sign. Participants were then
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screened for a history of brain, heart, vision, stomach, or inner ear problems. Participants
were also screened for pregnancy, vertigo, and past experience with virtual environments
and/or HMDs. Any participants answering yes to the previous screening questions were
not permitted to participate in the experiment. Participants were then given the MSHQ to
assess their motion sickness history and susceptibility to motion sickness.
Remaining participants were then escorted to the laboratory where the experiment
took place. The experimenter explained the object location task and asked if the
participant had any questions regarding this task. The participant was asked to stand in a
specific spot for the object location task and to hang on to a handrail placed in front of
them for the duration of the experiment. They were informed to not lock their knees
during the experiment, as this can decrease blood flow to the brain. Next, the participant
was guided through equipping the HMD. The experimenter helped participants put on
the HMD when necessary. When the participant indicated the HMD was adjusted
appropriately, the experimenter started the experiment. The experimenter then verbally
administered a pre-practice MSAQ and SSQ.
The HMD task required participants to make head movements while wearing the
HMD. Participants were asked to find objects around the lab based on their names and
locations. A voice recording was used to call out the name of the object and its relative
direction compared to where the previous object was located (e.g. left or right). The
object order was randomized. The maximum horizontal movement indicated by stimulus
arrangement was 180°. Participants were instructed to make movements with only their
head and neck. If necessary, slight shoulder movements were allowed, but participants
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were instructed to not make hip or leg movements during the task. Participants were
instructed to center the objects within the HMD display. In between trials, participants
were asked to look straight ahead at an ‘X’ placed on the front door.
Each participant completed two 48-second practice trials. The practice trials were
necessary for the participant to become familiar with the objects and their locations, as
well as to get a feel for the speed of the object location task. After both practice trials,
the experimenter again verbally administered the MSAQ and the SSQ.
The experiment entailed five two-minute experimental trials with a one-minute
break between trials. There were 40 head movements in each trial separated by three
seconds. During each trial, the experimenter recorded the accuracy of the head
movements via a monitor displaying the projected images in the HMD display. At the
end of each trial during the one-minute break, the experimenter verbally administered the
SSQ. After the final trial, the experimenter immediately verbally administered the
MSAQ and the SSQ while the participant was still wearing the HMD.
Participants were instructed that the goal of this experiment was not to make them
feel too uncomfortable and if at any time they started to feel to uncomfortable they
should let the experimenter know and the study would be stopped immediately. In
between each trial, the experimenter asked the participant if they felt fit enough to
continue with the experiment. If the participant felt too uncomfortable to continue with
the experiment, the experimenter instructed them to cease the object location task and
close their eyes. The experimenter quickly removed the HMD from the participant’s
head and helped them to a chair situated adjacent to where the participant was standing.
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The experimenter then asked the participant if they needed any water and made sure the
participant stayed seated until they felt better.
After completing five experimental trials, the participant was asked to take off the
HMD. The experimenter debriefed the participant on the purpose of the study and again
verbally administered the SSQ to make sure the participant was well enough to leave the
lab. Before the participants left, the experimenter compensated them with $10.
Data Analysis
Peak SSQ scores were used to measure simulator sickness among participants and
post experimental MSAQ scores were used to measure motion sickness among
participants. Each participant had eight total SSQ scores (completed before practice
trials, after practice trials, after trial 1, 2, 3, 4, and 5, and after experimental debrief) and
three total MSAQ scores (completed before practice trials, after practice trials, and after
experimental trials) upon completion of the experiment. The peak scores for SSQ were
used instead of the sum or the mean for two reasons: to be able to use participants who
withdrew from the experiment before completing all five trials, and to account for
varying onset and severity of simulator sickness across individuals.
A 2 x 2 between subjects analysis of variance (ANOVA) was run to determine if
there were significant differences in simulator sickness symptoms between the four
conditions. A second 2 x 2 between subjects ANOVA was run to look for significant
differences in motion sickness symptoms in each condition. The dependent variables
being analyzed for each test were the peak SSQ score and post experimental MSAQ score
for each participant, respectively. The independent variables were frequency of latency
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and amplitude of latency for both ANOVAs. Both independent variables had two levels
(0.2 Hz and 1.0 Hz in the frequency of latency condition, and 100 ms fixed amplitude and
20-100 ms varying amplitude in the amplitude of sinusoidal latency condition).
Another 2x2 ANOVA was run using post SSQ scores as the dependent variable,
and keeping frequency and amplitude of latency as the independent variables. This
analysis was run to make sure there were no significant changes between the peak and
post SSQ scores.
A mixed ANOVA was run to look for an effect of trial by condition. This
analysis used only participants who completed all five experimental trials. The peak SSQ
scores were used for the dependent variable. The between subjects independent variable
was assigned condition and the within subjects independent variable was trial.
To analyze participant withdrawal, a Fisher’s exact test was used. This test
compared the number of participants who did not complete all five experimental trials to
the number of participants who did. The independent variables for this analysis were
again frequency (0.2 Hz vs. 1 Hz) and amplitude (100 ms fixed vs. 20 – 100 ms varying)
of sinusoidal latency.

RESULTS
One hundred twenty four participants were recruited for this experiment (60
male). Initially, 120 participants were recruited. However, four participants in the 1 Hz
frequency 100 ms amplitude condition had peak SSQ scores greater than 3 standard
deviations from the mean. In each of these cases, factors not related to the experimental
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procedure may have contributed to their sickness, such as race and high susceptibility to
motion sickness. One participant dropped out of the study after locating only three
objects in the object location task and had severe symptoms (loss of vision and hearing
for a few seconds); one participant exhibited unusually high SSQ scores during the
practice trials; one participant dropped out after the third experimental trial with
unusually high SSQ scores; one participant was African American/Asian and had a high
MSHQ score (cf. the high MS genetic susceptibility in Asian populations; Stern et al.,
1996). Therefore, it was decided to replace them with additional participants. Of the
remaining 120 participants, there were 30 participants in each condition (14 males in
condition 1, 15 males in conditions 2, 3, and 4).
The mean age for all 120 participants was 19.4 years (SD = 1.51). The mean age
for males was 19.7 years (SD = 1.79), and the mean age for females was 19.1 years (SD =
1.14). Of the 120 participants, 25 did not complete all five experimental trials. All of
these participants reported feeling too uncomfortable to continue with the experiment due
to common SS symptoms such as dizziness, eyestrain, and nausea. Of the 25 participants
who stopped the HMD exposure early, two started to collapse right before stopping the
experiment and complained of being extremely lightheaded after the experiment, and two
vomited a few minutes after stopping the experiment.
Table 1 shows the number of participants whose peak SSQ scores occurred in
each of the five experimental trials. The frequency distributions for both peak SSQ
scores and MSAQ scores were positively skewed (see figures 12 and 13). However,
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distributions for each condition had a similar shape so it was determined the data could
be analyzed with analyses of variance (ANOVA) without transformation.
Trial Number
# participants with Peak SSQ occuring in this
trial

1
8

2
5

3
7

4
5

5
95

Table 3.1: Number of participants experiencing peak SSQ scores in each experimental
trial

Figure 3.1: Frequency distribution of peak SSQ scores for all conditions
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Figure 3.2: Frequency distribution of total MSAQ scores for all conditions

Tests of the Hypotheses
SSQ Results. To test if there were increased simulator sickness symptoms in the
.2 Hz frequency condition compared to the 1.0 Hz frequency condition as well is if there
were increased simulator sickness symptoms in the 20 – 100 ms varying amplitude
conditions compared to the 100 ms fixed amplitude conditions a 2 (frequency) x 2
(amplitude) ANOVA was conducted. Peak SSQ scores were used during analysis to
measure simulator sickness so participants who stopped HMD exposure early could still
be included in the analysis. Means and standard deviations for each condition were
calculated using peak SSQ scores for each participant (see Table 2). No significant main
effect of frequency, F(1, 116) = 1.27, p = 0.26, η2 = .011, or main effect of amplitude,
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F(1, 116) = 1.35, p = 0.25, η2 = .012, was found. There was also no significant
interaction, F(1, 116) = 0.61, p = 0.44, η2 = .005.
	
  

Frequency

Amplitude

100 ms fixed
20 – 100 ms varying

1 Hz
32.8 ± 24.6
46.8 ± 42.6
39.8 ± 35.2

.2 Hz
46.5 ± 44.2
49.2 ± 42.6
47.9 ± 43.1

39.6	
  ± 36.1	
  
48.0	
  ± 42.3	
  
	
  

Table 3.2: Table of peak SSQ total scores means, standard deviations, and sample sizes
for each condition
MSAQ Results. To test if there were increased motion sickness symptoms in .2
Hz frequency condition compared to the 1.0 Hz frequency condition as well is if there
were increased motion sickness symptoms in the 20 – 100 ms varying amplitude
conditions compared to the 100 ms fixed amplitude conditions a 2 (frequency) x 2
(amplitude) ANOVA was conducted. MSAQ total scores were used to measure levels of
motion sickness experienced by participants. Means and standard deviations were
calculated for each condition from total MSAQ scores from each participant (see table 3).
A significant main effect of frequency of latency was found, F (1, 116) = 4.19, p = .043,
η2 = .035. No significant main effect of amplitude of latency occurred, F(1, 116) = 0.14,
p = .71, η2 = .001. No significant interaction between frequency and amplitude of latency
was found, F(1, 116) = 0.30, p = 0.58, η2 = .003.
Frequency

Amplitude

	
  
	
  
	
  

100 ms fixed

1 Hz
28.3 ± 12.2

.2 Hz
39.3 ± 27.9

20 – 100 ms varying

32.3 ± 20.8

38.6 ± 28.2

35.5 ± 24.8	
  

30.3 ± 17.0

39.0 ± 27.8

	
  

33.9 ± 22.0	
  

Table 3.3: Table of MSAQ total scores means, standard deviations and sample sizes for
each condition
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Effect of trial. A mixed ANOVA was conducted to look at the effect of trial by
condition. The analysis was completed on only the 95 participants who completed all
five HMD trials. Figure 14 shows a graph of average SSQ total scores across the five
trials for each condition. A significant main effect of trial was found, F (1, 91) = 64.66, p
< .01, η2 = .42. No significant main effect of condition was found, F (1, 91) = .532, p =
.66, η2 = .017. No significant interaction was found between trial and condition, F(1, 91)
= .24, p = .87, η2 = .008.
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Figure 3.3: Line graph of average SSQ total score across experimental trials for each
condition.
Early Termination Analysis. Twenty-five participants were not able to
complete the five experimental trials and terminated HMD exposure. Table 4 shows the
number of participants that dropped out by condition. Expected cell counts were low
(near 5), so the assumptions for a chi square test were violated. Therefore, a Fisher’s
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exact test was run to examine effects of frequency and amplitude on early termination.
Data were collapsed across the two amplitude conditions to look for an effect of
frequency. No significant effect of frequency was found, p = .33. Data were also
collapsed across the two frequency conditions to look for an effect of amplitude. A
significant effect of amplitude was found, p = .011.
Frequency

Amplitude

1 Hz

.2 Hz

100 ms fixed

3/30

4/30

7/60

20 – 100 ms
varying

8/30

10/30

18/60

11/60

14/60

Table 3.4: Number of participants who did not complete the five experimental trials by
condition
Exploratory Data Analysis
Post Trial SSQ. Post trial SSQ scores were analyzed in addition to peak SSQ.
Means and standard deviations for each of the conditions are shown in table 5. No
significant main effect of frequency, F(1, 116) = 1.42, p = .26, η2 = .012, or amplitude,
F(1, 116) = 1.51, p = .22, η2 = .013 was observed and no significant interaction was
observed, F(1, 116) = .53, p .47, η2 = .005.
Frequency
1 Hz

Amplitude

.2 Hz

100 ms fixed

30.4 ± 25.2 44.4 ± 43.8

37.4 ± 36.1

20 – 100 ms
varying

44.6 ± 43.2 48.0 ± 43.7

43.3 ± 43.1

37.5 ± 35.8 46.2 ± 43.4
Table 3.5: Post Trial SSQ score means and standard deviations by condition
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Further examination of Amplitude of Latency. To further examine the
amplitude of latency variable, a 2x2 ANOVA was conducted using .2 Hz frequency
conditions from the current experiment and the .2 Hz frequency conditions from a
previous experiment. Means and standard deviations for each of these conditions are
shown in table 6. There was a marginally significant main effect of amplitude found,
F(1, 116) = 3.84, p = .052, η2 = .032. There was no significant effect of experimenter,
F(1,116) = .001, p = .98, η2 = .00. Finally, there was no significant interaction between
amplitude of latency and experimenter, F(1, 116) = 2.53, p = .12, η2 = .021.
	
  

Condition

Experimenter

.2 Hz, 100 ms fixed

.2 Hz, 20 – 100 ms varying

Matt

34.5 ± 33.5

60.8 ± 41.2

47.7 ± 39.5

Amelia

46.5 ± 44.2
40.5 ± 39.4

49.2 ± 42.6
55.0 ± 42.0

47.9 ± 43.1
	
  

Table 3.6: Peak SSQ means and standard deviations for .2 Hz frequency conditions in
previous and current study
DISCUSSION
Primary Purpose
The primary purpose of this study was to examine the effect of frequency (f = 0.2
Hz and f = 1.0 Hz) and amplitude (A = 100 ms and A = 20 – 100 ms) on varying latency
on simulator sickness and motion sickness in a head mounted display. It was predicted
that an increased level of simulator and motion sickness symptoms would occur in the 0.2
Hz frequency conditions and the 20 – 100 ms varying amplitude conditions. It was also
predicted that there would be a significant effect of trial, meaning sickness symptoms
would increase as exposure time to stimulus increased.
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Frequency and Amplitude and Their Relationship to Motion Sickness
Discussion of simulator sickness and motion sickness results. Analysis of
peak SSQ scores and post-trial MSAQ scores yielded similar results, with one notable
exception. It was hypothesized that simulator sickness and motion sickness would
increase during 0.2 Hz frequency conditions and 20 – 100 ms varying amplitude
conditions. This hypothesis was not supported using results from peak SSQ scores, and
was only partially supported using post MSAQ scores. A significant effect of frequency
of latency was found using MSAQ post trials scores, indicating that on average,
participants in 0.2 Hz conditions had higher symptoms of motion sickness. This finding
was not significant when using peak SSQ scores, however the data trended in the same
direction. The mean peak SSQ scores in both the varying amplitude conditions were
higher than the mean peak scores in the fixed amplitude conditions. Additionally, the
mean peak SSQ score for both .2 Hz frequency conditions was higher than the 1 Hz
frequency fixed amplitude condition and were relatively the same as the 1 Hz frequency
varying amplitude condition. These findings coincide with previous research indicating
humans are sensitive to motion around 0.2 Hz frequency (O’Hanlon & McCauley, 1974;
Donohew & Griffin, 2009; Donohew & Griffin, 2004; Golding, Phil, & Markey, 1996;
Golding, et al., 2001; Godling, et al., 2007; Bijveld, et al., 2008;Godling, et al., 2009; St.
Pierre, 2012; Diels & Howarth, 2013) and varying amplitude of latency being more
sickening than fixed amplitude of latency (St. Pierre, 2012).
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SSQ post trials. There was a discrepancy between significant results from peak
SSQ scores and MSAQ post trials scores (MSAQ scores resulted in a significant main
effect of frequency of latency, while peak SSQ trended in the same direction but were not
significant). Because of this, SSQ post trial scores were analyzed. Again, there were no
significant effects of frequency or amplitude of latency or an interaction using SSQ post
trial scores. However, when looking at the means for all conditions, both the varying
amplitude conditions were higher than the mean peak scores in the fixed amplitude
conditions. Additionally, the mean peak SSQ score for both .2 Hz frequency conditions
was higher than the 1 Hz frequency fixed amplitude condition and were relatively the
same as the 1 Hz frequency varying amplitude condition. The trend in these data follow
previous research indicating humans are highly susceptible to sickness when frequency is
around 0.2 Hz (O’Hanlon & McCauley, 1974; Donohew & Griffin, 2009; Donohew &
Griffin, 2004; Golding, Phil, & Markey, 1996; Golding, et al., 2001; Godling, et al.,
2007; Bijveld, et al., 2008;Godling, et al., 2009; St. Pierre, 2012; Diels & Howarth, 2013)
and varying amplitude of latency as more sickening than fixed amplitude of sinusoidal
latency (St. Pierre, 2012). Interestingly, these results also show that varying amplitude
increases simulator sickness when paired with a non-sickening frequency as compared to
fixed amplitude paired with the same non-sickening frequency. While an effect of
frequency may be more dominant, varying amplitude of latency, especially when paired
with non-sickening frequencies still seems to have an important effect on sickness
symptoms.
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Varying Amplitude of Latency and Participant Withdrawal. The current study
found a significant relationship between participant withdrawal and condition. A total of
25 participants did not complete all five experimental trials. This equates to 20.8% of all
participants. When determining whether frequency and/or amplitude of latency
significantly contributed to participant withdrawal, a significant effect of amplitude was
found on early termination rate. These results indicate that significantly more
participants had to terminate their participation before the end of the experiment in the
varying amplitude conditions than in the fixed amplitude conditions. There was not a
significant difference in early termination rate between the .2 Hz conditions and the 1 Hz
conditions. This finding further supports previous research suggesting that there is in fact
an effect of varying amplitude of latency on simulator sickness (St. Pierre, 2012). While
significant effects of frequency were found via survey data collected from this
experiment, the significant effect of amplitude on early termination rate argues that
amplitude, as well as frequency, is an important contributing factor to simulator sickness
in HMDs. The effect of amplitude on early termination rate raises the point that varying
amplitude may lead to more severe sickness symptoms than the effect of frequency of
latency on sickness when there is incidence of sickness in the participant, leading the
participant to stop the experiment early. This idea should be further examined in future
experiments and will be discussed more extensively in the “Future Work” section.
Previous Studies and the Current Experiment. To further examine the effect of
amplitude of latency on simulator sickness, results from the current study were compared
to results from St. Pierre’s 2012 study. Both studies had the 0.2 Hz, 100 ms fixed
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amplitude and the 0.2 Hz, 20-100 ms varying amplitude conditions. When looking at
only these two conditions in both experiments, a marginally significant effect of
amplitude of latency was found. This result shows that participants in the varying
amplitude conditions demonstrated significantly higher sickness symptoms than those in
the fixed amplitude conditions. This finding suggests that amplitude of latency does
indeed play a role in simulator sickness along with frequency of latency, and that varying
amplitude of latency results in significantly greater sickness symptoms than fixed
amplitude of sinusoidal latency.
Effect of Trial. The hypothesis predicting there would be increased sickness
symptoms with increased duration of exposure to stimulus was supported. Analyzing
effect of trial revealed a significant main effect of trial during this study, meaning
sickness symptoms increased as trials increased. Participants reported increased sickness
symptoms the longer they were in the experiment. This increase was consistent across all
four experimental conditions; there was no difference in increase depending on
experimental condition. This analysis only included participants who completed all five
experimental trials so the effect of time while exposed to the stimulus could be accurately
examined. No significant effect of condition was found in terms of effect of trial,
indicating that regardless of the condition each participant was in, sickness symptoms
systematically increased over time. This finding aligns with previous research
concluding that longer exposure time leads to increased sickness levels (Moss, 2008; St.
Pierre, 2012).
Virtual Environments and Head Mounted Displays
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Designers of HMDs and virtual environments are faced with a tradeoff between
enhancing optical realism and decreasing system latency (Moss, 2008). Hettinger and
Riccio found evidence that pictoral realism contributes to system latency (1992). Many
studies found evidence to support the idea that system latency has the potential to cause
simulator sickness (DiZio & Lackner, 1997; Jennings, et al., 2004). Recent findings
specify that this system latency is varying, and not constant, which could be a
contributing factor in simulator sickness as well (Wu, Dong, & Hoover, 2013). Findings
from the current study, in addition to findings from St. Pierre, support this notion that
variable latency increases simulator sickness and that both frequency and amplitude of
latency are important factors in simulator sickness (2012). If system latency has to be
compromised when designing virtual environments and HMDs, then designers should
make sure amplitude of latency is not varying and frequency of latency is not around 0.2
Hz. While latency will still be prevalent and perhaps noticeable by humans, following
these guidelines should reduce sickness among users.
Motion Sickness and Simulator Sickness
Findings from this experiment contribute to the existing knowledge of simulator
sickness. The results from this experiment as well as past experiments from the Applied
Human Psychophysiology Laboratory at Clemson University show that variable latency
is a key factor in experiencing simulator sickness in HMDs. More specifically, from the
current and previous experiments it is known that humans are highly susceptible to
sickness when frequency of latency is around 0.2 Hz or when amplitude of latency is
varying between 20 – 100 ms. Having a better understanding of simulator sickness can
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help prevent sickness symptoms in the future. This experiment aids in identifying
specific relationships between frequency and amplitude of latency and simulator sickness
in HMDs and contributes to research dedicated to helping people adapt to and/or
overcome added latency in HMDs. Results from this experiment can also contribute to
designing HMDs for future use to reduce simulator sickness in users by potentially
reducing variable latency, making sure frequency of latency is not in the 0.2 Hz range,
and keeping amplitude of latency from varying. Virtual environments and HMDs are
used to advance fields such as medicine, engineering, design, training, and entertainment.
Virtual environments can be used for training when on the job training is too risky. If
users are experiencing motion sickness or simulator sickness from this training, it may
lead to poor job performance, loss of equipment, or loss of health to the user. Continuing
this line of research will positively impact many jobs that require employees to interact
with virtual environments or HMDs on a daily basis, such as teleoperations and other
military personnel, laparoscopic surgeons, and astronauts.
Limitations
There are a few limitations to this study that should be noted. First, the study was
a between-subjects design, and therefore individual differences play a role in the results.
While participants were screened to minimize individual differences in motion sickness
susceptibility, it is recommended that a within-subjects design be used in future studies.
Also, all participants were between the ages of 18 and 27 years, and were primarily
Caucasian, resulting in a narrow sample size regarding age and race, both of which can
be factors in motion sickness susceptibility (Golding, 2006). There was an even number

46

of male and female participants in the current experiment, but there was always a female
experimenter administering the study, which could have affected the results of the
surveys differently for male and female participants.
Another limitation to the current experiment is potential reporting bias from
participants. All data analyzed for the current study were survey responses, and the
experimenter administered all surveys verbally. This procedure could have caused some
participants to not be truthful in their responses to the surveys, or to not acknowledge
their symptoms completely to the experimenter.
A possible confound in this paradigm is that participants were required to remain
standing for the duration of the experiment. While participants were frequently reminded
to not lock there knees, it is possible that some participants did lock their knees, causing
them to feel light headed or some other symptom of simulator sickness.
There is a possible limitation in the surveys used to collect sickness symptom
data, as the MSAQ yielded a significant main effect of frequency of latency and the SSQ
did not. There are many possible explanations for this finding, for example, the two
questionnaires are measuring two different syndromes: motion sickness and simulator
sickness. While these syndromes are similar, there are some differences in experienced
symptoms (Bijveld, et al., 2008). This discrepancy could also be due to the two
questionnaires having different dimensionalities (using a 1 – 9 scale vs. None, Slight,
Moderate, Severe scale), incorporating different items, or being administered at different
times during the experiment (just pre and post trials vs. between all experimental trials).
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Finally, the current experiment only looked at two frequencies of latency (f = 0.2
Hz and f = 1.0 Hz) out of the continuum of possible frequencies. This limits the
generalizability of the results found, because only few frequencies relative to all possible
frequencies have been tested in this paradigm. Additionally, only two types of
amplitudes of latency were tested (A = 100 ms and A = 20 – 100 ms), again limiting the
generalizability of the results.
Future Work
In the future, a within-subjects design should be used to avoid individual
differences and reduce error variance in the data. Survey data should be collected
without verbal administration. One way this could be done is project the survey in the
HMD between experimental trials so participants can read and complete the surveys by
themselves, without the help of the experimenter. Additionally, physiological data
should be coupled with survey data to avoid reporting bias from participants.
Future studies should further examine the role of amplitude of latency on both
incidence and severity of simulator sickness. There are numerous previous studies
looking at the effects of frequency, specifically 0.2 Hz frequency, on sickness, and there
is overwhelming evidence that 0.2 Hz frequency causes humans to be extremely
susceptible to sickness (O’Hanlon & McCauley, 1974; Donohew & Griffin, 2009;
Donohew & Griffin, 2004; Golding, Phil, & Markey, 1996; Golding, et al., 2001;
Godling, et al., 2007; Bijveld, et al., 2008;Godling, et al., 2009; St. Pierre, 2012; Diels &
Howarth, 2013). However, there is a gap in the literature when it comes to varying
amplitude of latency and simulator sickness (St. Pierre, 2012).
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Experimenters should continue to look at varying amplitude of latency,
specifically in known non-sickening frequencies. Both fixed and varying amplitude
should be tested, using fixed amplitude as a control group. Frequencies between 0.2 Hz
and 1.0 Hz should be incrementally coupled with fixed and varying amplitude to fully
examine the relationship between sickening and non-sickening frequencies and varying
amplitude. The current study found a significant effect of amplitude of latency on early
termination rate of participants. This finding may indicate that upon incidence of
sickness, varying amplitude results in more severe symptoms than 0.2 Hz frequency.
This idea needs to be further explored in future studies by noting early termination rate of
participants. This idea can also be looked at using physiological data in addition to
survey data to determine the severity of symptoms when participants are experiencing
simulator sickness. Future work in this area has the potential to solidify the notion that
varying amplitude contributes to simulator sickness, and will give insight on the extent to
which varying amplitude matters in system latency.
Conclusion
In conclusion, results from this study support previous findings showing an effect
of frequency on simulator sickness, specifically 0.2 Hz frequency causing an increase in
sickness symptoms. Results from this study provide evidence that amplitude of latency
plays a role in simulator sickness as well, but the specific role of amplitude of latency
needs to be further explored in future studies. Findings from this experiment contribute
to the overwhelming evidence that humans are sensitive to 0.2 Hz frequency found in
previous studies (O’Hanlon & McCauley, 1974; Donohew & Griffin, 2009; Donohew &
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Griffin, 2004; Golding, Phil, & Markey, 1996; Golding, et al., 2001; Godling, et al.,
2007; Bijveld, et al., 2008;Godling, et al., 2009; St. Pierre, 2012; Diels & Howarth,
2013). Results from this study show a trend toward a significant main effect of amplitude
of latency, which has not been explored extensively prior to this experiment. In 2008 the
Applied Human Psychophysiology Laboratory began to examine the cause of sickness
when wearing an HMD. Moss (2008) found marginal support for his hypothesis that
update delay contributed to sickness. Then Wu, Dong, and Hoover (2013) found variable
latency in HMDs. Results from St. Pierre (2012) and the present study supports the
notion that this variable latency is contributing to the problem of simulator sickness in
HMDs.
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Appendix A
1 Hz Frequency, 100 ms fixed Amplitude

Recording
81
82
87
88
89
90
91
92
93
94
Average
Standard
Deviation

Recording
81
82
87
88
89
90
91
92
93
94
Average
Standard
Deviation

No fixed variables
K
A
162.91 86.09
168.98 101.31
181.06 105.23
168.38 110.21
164.85 83.29
157.59 79.20
166.16 108.33
187.85 101.87
183.36 84.19
190.89 90.26

F
1.07
1.00
0.83
0.72
1.19
0.98
0.89
1.07
0.90
1.06

Phi
0.96
-1.44
0.96
2.18
-0.78
-0.77
0.13
0.54
-0.76
0.16

173.20

95.00

0.97

0.12

11.56

11.57

0.14

1.09

K fixed to 180
K
A
180.00 101.10
180.00 105.77
180.00 105.01
180.00 28.96
180.00 107.49
180.00 121.62
180.00 86.63
180.00 103.98
180.00 85.38
180.00 94.68

F
0.77
1.03
0.84
4.77
0.93
0.72
1.10
1.06
0.91
1.04

Phi
2.06
-1.57
0.92
0.14
-0.29
-0.16
-0.19
0.54
-0.76
0.22

180.00

94.06

1.32

0.09

0.00

25.20

1.22

0.98
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Recording
81
82
87
88
89
90
91
92
93
94
Average
Standard
Deviation

Recording
81
82
87
88
89
90
91
92
93
94
Average
Standard
Deviation

K fixed to 180 AND A fixed to 100
K
A
F
Phi
180.00 100.00
0.77
2.06
180.00 100.00
1.03 -1.58
180.00 100.00
0.83
0.92
180.00 100.00
0.71
2.44
180.00 100.00
0.93
2.87
180.00 100.00
0.65
3.11
180.00 100.00
1.09 -0.21
180.00 100.00
1.06
0.54
180.00 100.00
0.90 -0.73
180.00 100.00
1.04
0.21
180.00

100.00

0.90

0.96

0.00

0.00

0.16

1.60

K fixed to 180 AND F fixed to 1.0
K
A
F
Phi
180.00
82.15 1.00
1.21
180.00 105.56 1.00 -1.47
180.00 105.24 1.00
0.30
180.00 116.40 1.00
1.93
180.00 107.13 1.00 -0.45
180.00 129.76 1.00 -0.54
180.00
85.62 1.00
0.03
180.00 103.54 1.00
0.85
180.00
82.00 1.00 -1.10
180.00
94.00 1.00
0.42
180.00

101.14

1.00

0.12

0.00

15.45

0.00

1.05
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0.2 Hz Frequency, 100 ms fixed Amplitude

Recording
95
96
97
98
99
100
101
102

No fixed variables
K
A
105.49
258.10
-1524.70 3534.20
-2812.40 6115.50
146.96
21.40
195.42
45.61
1057.70 1971.60
-855.71 2158.20
164.00
203.18

Average
Standard
Deviation

Recording
95
96
97
98
99
100
101
102
Average
Standard
Deviation

F
Phi
0.13 1.74
0.05 1.38
0.04 1.41
1.10 -2.83
0.41 -1.53
0.02 1.09
0.03 -1.39
0.20 1.03

-440.40

1788.47

0.25

0.11

1232.39

2169.80

0.37

1.75

K fixed to 180
K
A
180 205.86
180 126.70
180 132.64
180 733.40
180 71.63
180 214.84
180 38.85
180 172.23

F
Phi
0.12 2.43
0.27 0.50
0.26 0.37
0.01 3.26
0.27 -0.48
0.09 -0.03
1.14 4.08
0.22 0.95

180

212.02

0.30

1.39

0

219.33

0.35

1.66
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Recording
95
96
97
98
99
100
101
102
Average
Standard
Deviation

Recording
95
96
97
98
99
100
101
102
Average
Standard
Deviation

K fixed to 180 AND A fixed to 100
K
A
F
Phi
180
100
0.30
1.35
180
100
0.23
0.72
180
100
0.21
0.64
180
100
0.09
-0.99
180
100
0.30
-0.58
180
100
0.20
0.06
180
100
0.22
2.42
180
100
0.21
0.95
180

100

0.22

0.57

0

0

0.06

1.08

K fixed to 180 AND F fixed to .2
K
A
F
Phi
180 138.07
0.20
1.98
180 116.08
0.20
0.96
180 120.29
0.20
0.73
180
78.56
0.20
10.92
180
66.28
0.20
-0.20
180 127.02
0.20
-0.17
180 118.01
0.20
-0.68
180 173.04
0.20
1.13
180

117.17

0.20

1.83

0

33.27

0.00

3.77
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1.0 Hz Frequency, 20 – 100 ms varying Amplitude

Recording
105
106
107
108
109
110
111
112
113
114
115
116
Average
Standard
Deviation

No fixed variables
K
A
F
172.17 70.61 0.91
176.73 57.94 1.02
169.59 22.38 2.47
178.52 59.92 1.25
185.84 82.89 1.10
187.75 54.50 1.08
190.13 81.58 0.95
190.75 47.14 0.94
180.77 54.31 1.07
179.93 47.40 1.09
197.52 78.54 1.03
180.17 15.12 1.11

Phi
-1.00
-0.66
2.06
-1.63
10.61
-0.14
2.53
1.69
0.90
0.36
0.32
-1.13

182.49

56.03

1.17

1.16

8.13

21.48

0.42

3.25
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Recording
105
106
107
108
109
110
111
112
113
114
115
116
Average
Standard
Deviation

Recording
105
106
107
108
109
110
111
112
113
114
115
116
Average
Standard
Deviation

K fixed to 180
K
A
180
64.33
180
60.66
180
43.14
180
58.44
180
81.90
180
60.25
180
20.04
180
42.93
180
54.24
180
47.36
180
81.21
180
15.21

F
1.07
0.94
1.22
1.29
1.10
1.06
2.31
0.97
1.07
1.09
1.01
1.10

Phi
-1.47
-0.48
8.96
-1.76
10.68
-0.07
-4.24
1.32
0.89
0.36
0.32
-1.10

180

52.48

1.19

1.12

0

20.55

0.37

4.33

K fixed to 180 AND A fixed to 60
K
A
F
Phi
180
60
1.08
-1.49
180
60
0.94
2.66
180
60
1.23
-2.73
180
60
1.29
-1.75
180
60
1.12
1.80
180
60
1.06
-0.07
180
60
0.97
2.32
180
60
0.97
1.36
180
60
1.07
0.89
180
60
1.10
0.33
180
60
1.01
0.36
180
60
1.10
-1.02
180

60

1.08

0.22

0

0

0.10

1.70
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Recording
105
106
107
108
109
110
111
112
113
114
115
116
Average
Standard
Deviation

K fixed to 180 AND F fixed to 1.0
K
A
F
Phi
180
65.71
1.00
-1.27
180
59.60
1.00
-0.63
180
40.45
1.00
32.66
180
54.60
1.00
-1.12
180
82.14
1.00
-0.83
180
57.79
1.00
0.15
180
74.57
1.00
-1.02
180
42.75
1.00
1.16
180
53.28
1.00
1.22
180
44.80
1.00
0.72
180
81.12
1.00
0.38
180
14.86
1.00
-0.87
180

55.97

1.00

2.55

0

19.10

0.00

9.53
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0.2 Hz Frequency, 20 – 100 ms varying Amplitude

Recording
117
118
119
120
121
122
Average
Standard
Deviation

Recording
117
118
119
120
121
122
Average
Standard
Deviation

No fixed variables
K
A
927.64 1657.40
753.63 1948.90
4251.10 8947.30
2505.10 5470.40
170.13
69.06
96.90
531.83

F
Phi
0.02 2.09
0.02 -1.40
0.01 1.54
0.03 1.46
0.37 -5.91
0.00 2.76

1450.75

3104.15

0.08

0.09

1623.95

3435.05

0.15

3.26

K fixed to 180
K
A
180
147.62
180 2186.30
180
85.45
180
103.14
180
57.47
180
393.01

F
0.11
0.01
0.17
0.22
0.48
0.01

Phi
5.94
3.11
1.15
0.63
0.02
3.06

180

495.50

0.16

2.32

0

837.17

0.18

2.18

59

Recording
117
118
119
120
121
122

K fixed to 180 AND A fixed to 60
K
A
F
Phi
180
60
0.24
2.39
180
60
0.20
2.02
180
60
0.13
1.18
180
60
0.18
0.89
180
60
0.48
0.01
180
60
0.30
0.20

Average
Standard
Deviation

Recording
117
118
119
120
121
122
Average
Standard
Deviation

180

60

0.25

1.12

0

0

0.12

0.96

K fixed to 180 AND F fixed to .2
K
A
F
Phi
180
93.54
0.2 -19.49
180
61.04
0.2 -13.71
180
86.66
0.2
0.87
180 100.88
0.2
0.81
180
68.12
0.2
1.96
180
25.70
0.2
0.94
180

72.66

0.2

-4.77

0

27.53

3.04047E-17

9.35

60

Appendix B
Examples of the four graphs showing system latency with fitted sine waves for
each condition are shown below. The graph in the top left corner shows the sine wave
fitted with no variables fixed. The graph in the top right corner shows the sine wave
fitted with constant offset (k) fixed to 180. The graph in the bottom left corner shows the
sine wave fitted with constant off set and amplitude (A) fixed. The graph in the bottom
right corner shows the sine wave fitted with constant off sent and frequency (f) fixed.

1.0 Hz Frequency, 100 ms Amplitude, 100 ms Constant Offset
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0.2 Hz Frequency, 100 ms fixed Amplitude, 100 ms constant offset

1.0 Hz Frequency, 20 – 100 ms varying Amplitude, 100 ms constant offset
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.2 Hz Frequency, 20 – 100 ms varying Amplitude, 100 ms constant offset
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